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Toxicity Tests in Animals: Alternative Models
Editor's Note: This article is the second ofa
three-part series on the use ofanimal models
in toxicity testing. Thefirstpart exploredtra-
ditionaluses ofanimals in toxicitytesting; the
thirdpart willdiscuss the use ofanimal data
in human riskassessment.
We have come a long way since the days,
early in the century, when Dr. E.V.
McCollum, to the amazement and con-
sternation of his fellow Kansan farmers,
raided corncribs for mice and rats to use
for nutrition experiments. McCollum
believed that it was essential to experiment
with small animals with a short life span.
His rat colony, started in 1908, was the
first in the United States to be used for
nutritional investigations, resulting in
information on the importance ofvitamins
and other dietary elements. McCollum,
were he alive today, would likely be at the
forefront of the movement to develop
alternatives to traditional animal models
for experimentation and toxicity testing.
Technical improvements in
tissue culture and the develop-
ment of the Ames test, which
uses bacteria to detect muta-
gens, challenge the view that
animal testing is the only option
in toxicity testing. In addition,
there has been a growing recog-
nition of the limitations of cer-
tain standard in vivo testing
procedures. The explosion of
knowledge in molecular biology
has also significantly affected
toxicology. Moreover, the costs
of assessing potential health
effects of some 200,000 sub-
stances per year that are newly
identified or synthesized neces-
sitate alternatives to animal test-
ing. It has been estimated that
the cost of testing a single sub-
stance using whole animals is
frequently in excess of $2 mil-
lion. In addition, in vitro test-
ing provides the researcher with
considerably more control of
the variables than whole-animal
testing. However, the new tools
for toxicity testing must be
looked on as adjuncts to tradi-
tional testing methods. Any
testing method has inherent dif-
ficulties: when using whole ani- Mini labs.
mals data must be extrapolated transparei
from one species to another, and when
using cell or tissue culture data must be
extrapolated to the whole organism.
The quest for alternatives to animal
testing has been scientifically driven,
according to William Stokes, associate
director for Animal and Alternative
Resources at NIEHS. New testing meth-
ods that more accurately assess hazards, are
less expensive, and more rapidly determine
toxicity are being sought at NIEHS. It is
the pursuit of these goals that account for
the great progress in alternative testing
techniques.
Franklin Loew, dean of the Tufts
Veterinary School, says it "became clear in
the early 70s, apart from the ethical, scien-
tific, and technical issues, that routine use
ofrats, mice, and guinea pigs in toxicology
was becoming increasingly expensive and
time-consuming at the same time that
society wanted rapid answers. Issues like
saccharin and bladder tumors drove the
work in this field toward a faster, cheaper,
;.Teratogenic effects of chemicals show up early and read
nttadpoles.
smarter system." Alternative tests raise
complex issues. If the standard two-year
rodent carcinogen test is accurate at the
90% level, is a two-week or two-month
nonanimal test using bacteria which is
cheaper, quicker, and only 80% accurate
acceptable? The trade-offs of lower cost,
speed, and increased accuracy are consid-
ered respectable goals, according to Loew.
Ultimately the question is one of public
policy.
History ofComparative Toxicology
Marcello Malpighi forecast in vitro toxi-
cology when he wrote: "The nature of
things, enveloped in shadows, is revealed
only by the analogical method. Hence the
necessity to follow it entirely . to ana-
lyze the most complex mechanisms by
means of simpler ones." Malpighi went
on to describe his attraction to the investi-
gation of insects and plants, and mused
that perhaps he should go even further, to
study minerals and elements in order to
draw conclusions about the human organ-
ism.
Malpighi's contemporary, Anton van
Leeuwenhoek, inspired by the glass-
* ~ es used by drapers to inspect the
_ m quality ofcloth, constructed the first
-9 microscope. With his invention he
investigated sexual reproduction and
the transport system of nutrients in
* plants and animals.
* Experimental research based on
sophisticated analytical procedures
5 accelerated in the early 20th centu-
ry. Industrial toxicology has gained
great importance because of the
expansion ofindustry, the growth of
I all branches of chemistry (organic,
food, medicinal), and the recogni-
tion ofthe rights ofworkers and the
public to protection from possible
hazards. Worker protection was
brought forward by a tenacious
physician named Alice Hamilton
who, in her autobiography Explor-
ing the Dangerous Trades, gave a
graphic account of the history of
industrial toxicology in the United
States.
Rex Burch and W.M.S. Russell's
seminal work, The Principles of
Humane Experimental Technique,
published in 1959, pointed the way
to reducing the number of animals
used in research refining procedures
by improving the design and effi-
lily in ciency oftesting and thereby reduc-
ing animal pain and distress, and
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replacing whole animals with tissue cul-
tures, microorganisms, and other tools.
This concept of reduction, refinement,
and replacement is now commonly re-
ferred to as the "three R's" ofalternatives.
Though in vitro toxicology is a very young
science and cannot replace animal testing
at this point, its potential is vast, and its
current use as an initial screen for in vivo
testing is invaluable. In addition, research
into alternative models give us a better
understanding ofthe whole organism.
Perspectives
Alternatives to whole-animal testing
include endpoint assays, cell and tissue
cultures, the use of tissue slices, toxicoki-
netic modeling, and structure-activity
relationships and databases. Some exam-
ples of nonwhole animal methods include
the use of bacteria and yeast to assess
mutagenicity, chick embryos to assess ter-
atogenicity, and fixed enzyme systems to
screen for biological effects.
Alan Goldberg, director of the Center
for Alternatives to Animal Testing at the
Johns Hopkins University School of
Hygiene and Public Health, says that the
main questions concerning the use of
alternatives are 1) How do we extrapolate
from an in vitro system to an in vivo sys-
tem (i.e., how do we relate effects in single
cells to complex interactions in whole ani-
mals)? 2) How do we use available in vitro
and in vivo data to design better experi-
mental approaches? and 3) How do we
predict potential biological effects from
the chemical structure ofa substance?
Concordance between results from
alternative tests and those from mammals
is an important issue in protecting the
public safety. It is also important to note
that research using cells, tissue cultures, or
nonmammalian systems is conducted not
only as an alternative to using mammals
but because a given alternative system best
answers the question under study. In vitro
studies also allow researchers to under-
stand the discrete steps in a specific
sequence of events leading to toxicity,
which is difficult to do in whole animals.
Nonmammalian Models
In place of traditional animal models,
nonmammalian vertebrates such as fish,
amphibians, reptiles and birds with certain
characteristics in common with mammals
are being studied. For instance, chemical
transmisson in nerve cells has been illumi-
nated by study of the frog neuromuscular
junction.
A central issue in the use of nontradi-
tional animal models is how highly con-
served a particular organ or biological sys-
tem is and therefore how well a given sys-
tem correlates with the human one. As
Stokes points out, "Where you have highly
conserved structures or mechanisms, you
can use the lowest phyloge-
netic organism or system,
whether in tissue cultures or
whole organisms like the
nematode to extrapolate to
the human response." Stokes
is currently investigating the
usefulness of the frog em-
bryo teratogenesis assay
xenopus (FETAX) system.
Fertilized frog eggs that de-
velop into free-swimming
tadpoles in 96 hours are used
to assess the teratogenic po-
tential of chemicals. Using a Melvin Anders
dissecting microscope, one make it possib
can observe any perturbation to human respc
in the development of the
embryo as it is exposed to known terato-
gens in a petri dish.
The use of invertebrates, particularly
insects, has provided fundamental insights
into living processes. Research on the eye
pigmentation of Drosophila led to the
hypothesis that each gene controls a single
enzyme, a concept fundamental to modern
molecular biology. The giant squid axon
has provided the basis for the concept of
the ionic nature of the electrical action
potential in nerve transmission. Inver-
tebrates with nervous systems biochemical-
ly related to humans are commonly used
for neurotoxicity tests. In a study pub-
lished in Cancer Research in 1988, Muller
et al. studied the neurons of freshwater
snails as a possible model for testing neuro-
toxic side effects ofantitumor agents.
Microorganisms are used as models in
metabolism, genetics, and biochemistry
and can sometimes serve as models ofmore
complex systems. For instance, what is
learned about mechanisms ofgene expres-
sion may be applied to the study ofnormal
and pathological development of human
embryos. It has been shown that yeast has
receptors for estrogen that appear to be
identical in affinity with those of the rat
and human uterus.
One reason cell and tissue culture sys-
tems are valuable in toxicity testing is that
they can be observed with a light micro-
scope while various components ofthe sys-
tem are manipulated. For instance, one can
observe the beating of cultured heart cells
and note the effects of adding various
chemicals to the culture medium. Human
oral fibroblasts are used for testing dental
materials, and cell mats have been used for
screening human tumors for sensitivity to
anticancer drugs.
Mathematical Models
Other in vitro systems and mathematical
models are playing key roles in the rapidly
sen-
ble 1
onse
accumulating armory of alternatives.
Intermediary metabolism using synthe-
sized biochemicals, reaction
rates, and the role of cata-
lysts can be studied. Math-
ematical models can sup-
plement and sometimes re-
duce the number ofbiolog-
ical studies necessary.
Melvin Andersen of the
U.S. EPA works with phar-
macokinetic models to elu-
cidate processes at the mol-
ecular, biochemical, cellu-
lar, and organ system levels.
According to Andersen,
-In vitro data such processes "determine
to extrapolate the delivery of chemicals to
target tissues and the re-
sponses of tissues to the
chemicals." Pharmacokinetic models
encode biological relationships in mathe-
matical form and permit extrapolation
from high to low doses, from one species
to another, and from one dose route to
another. These models also provide a
method to extrapolate from relevant para-
meters determined in vitro to expected
behavior in vivo, using quantitative data
on tissue solubilities/tissue binding, tis-
sue-toxicant interactions, rates ofmetabo-
lism, and concentration response in vitro.
Using in vitro data, it is possible not
only to extrapolate to human response but
to look at the pharmacokinetics of other
species, Andersen notes. "The ability to
conduct interspecies extrapolations with
physiological models arises from the fact
that these models are developed with a
mechanistic understanding of the factors
which determine the disposition of a
chemical." Such models contain the criti-
cal biological determinants of uptake and
disposition ofa given chemical. Andersen
states that the "integration of these deter-
minants within the physiological structure
permits scaling to any other species of
interest, including humans. The ability to
account for differences in the physiological
and biochemical parameters among vari-
ous biological species with a physiological
model reduces the need for conducting
studies in larger laboratory animal species
to predict human dosimetry."
John M. Frazier, of the Division of
Toxicological Sciences at Johns Hopkins
University, addresses the issue of corre-
spondence between in vitro and in vivo
dose-response relationships and the role of
in vitro toxicity testing systems in the safe-
ty evaluation process. "The cornerstone of
any toxicological evaluation is the estab-
lishment ofthe dose-response relationship
which is used to predict the degree ofbio-
logical response expected under various
levels of exposure. The objective is to
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identify the most sensitive
adverse biological response
expected and determine a
safe level of exposure at
which the probability of ex-
periencing any adverse ef-
fects is low enough to be
acceptable to society," Fraz-
ier states. The major compo-
nents of the dose-response
relationship are toxicokinet-
ics (all kinetic processes that
determine the relationship
between the exposure dose
and the delivered dose), initi- John Frazier-
ation (the molecular reaction ieityatesting between the active form of
the toxicant and the molecular target), and
toxicodynamics (the sequence ofevents set
offby initiation reactions at the molecular
level and cascading to higher levels ofbio-
logical organization, culminating in mea-
surable effects).
In vitro systems have provided infor-
mation on metabolic pathways and mech-
anisms of action and have identified
appropriate animal models for extrapolat-
ing to humans. The in vitro system can
serve as the "central core of the toxiologi-
cal process," says Frazier, providing infor-
mation about the initiation process as well
as the molecular and cellular components
of the toxicodynamic phase. "The devel-
opment ofthe scientific basis ofpredictive
toxicokinetics focused on physical-chemi-
cal properties, quantum mechanical calcu-
lations, and in vitro measurements of
metabolism." Frazier points out that if
human cells were used, species extrapola-
tion would be less important and only a
minimal amount of animal study would
be needed to confirm in vitro findings.
Structure-Activity Studies
Herbert Rosenkranz ofthe Department of
Environmental and Occupational Health
in the School of Public Health at the
University ofPittsburgh has been involved
for a number ofyears in nonanimal testing
to predict health effects. Rosenkranz says
that in order to go to the next step, a com-
puter program must be used.
Rosenkranz observes that often the
importance of negative information is
overlooked: a "positive observation is
important only against a background of a
mass of negative information," he says.
For example, in the field of toxicology,
one tends to focus and report on carcino-
gens and rarely asks what is the difference
between the carcinogens and the noncar-
cinogens. However, if one only looks at
carcinogens, one may be driven into
assigning causality to a property, say, elec-
trophilicity, that seems to be prevalent in
these carcinogens. However, a more com-
-Dose-response
are the core oftox-
plete analysis may uncover
the fact that many noncar-
cinogens also exhibit that
same property, thereby in-
validating the predictive
value ofthis property."
The Computer Auto-
mated Structure Evaluation
(CASE) program uses the
difference between active
(biophores) and inactive
(biophobes) molecules to
identify the factors that
best discriminate between
them. Rosenkranz uses a
linguistic analogy to illus-
trate this: to create a com-
puter program with the capacity to distin-
guish between words in English, German,
or gibberish, "we submit to the program a
learning set consisting of a number of
English words and non-English words."
Once read by the program, the word will
be "cut into pieces of three or more adja-
cent letters," creating groups of lettters
that can be identified as belonging to
English, German, or neither. "Once the
program has digested the learning set and
identified the relevant attributes of the
language, it can be challenged by a word it
has never encountered before and, as we
do, try to classify the word by the way it
sounds. The CASE program follows such
an algorithm to identify the structural
attributes oftoxicity from a learning set of
molecules ofknown activity."
Other programs being developed in-
clude MULTICASE and the META pro-
gram, which can identify molecular sites
susceptible to metabolic transformation.
Such programs are currently being used to
evaluate the activity of diverse molecules
and the location ofmetabolic pathways to
predict toxicity, and the results show a
high level ofconcordance with short-term
assays.
A recent work-
shop held at NIEHS
brought together f- +
some 200 scientists
and professionals to
try to predict the out-
comes of 44 rodent
cancer bioassays be- ol
fore the results of the
studies were made
known (see NIEHS
News, p. 284). Partic- ,
ipants provided over-
views of their predic-
tion methods and e -.
evaluated thestrengths
and weaknesses ofthe
methods. Strengths
included success in Answers under glas
predicting strongly mechanisms of actior
carcinogenic chemicals, the ability to
ascertain classes of chemicals suitable for
specific tests, and the potential of all sys-
tems to be improved. Weaknesses includ-
ed a lack of understanding of the precise
mechanisms ofcarcinogenicity, which lim-
its the ability to completely evaluate the
relevance ofanimal results to estimation of
human risks.
Advances in molecular biology have
increased the understanding of cellular
and molecular processes and the differ-
ences in these processes between humans
and animals. Tools from cellular and mol-
ecular biology are being used to develop
research strategies for identifying primary
target genes. According to William
Greenlee, a dioxin researcher at Purdue
University, the effect of dioxin, through
gene regulation, on growth and differenti-
ation of human skin can serve as a basis
for "comparative studies with rat liver cells
where dioxin-dependent actions on
growth and differentiation lead to tumor
production." Apart from understanding
the relevance to humans of a given re-
sponse in rodents, biological mechanism-
based approaches are needed to determine
ifthe most sensitive response in an animal
model is necessarily relevant to humans.
Thomas Sutter, a researcher at Johns
Hopkins University, says that because of
the extensive knowledge ofdioxin's mech-
anism of action, a biologically based
model for risk assessment that might elim-
inate some ofthe sources ofuncertainty in
current risk estimates is being investigated.
(See Lucier et al., EHP 101:36-44.) "The
dioxin risk reassessment provides a unique
opportunity to demonstrate the utility of
human in vitro systems to generate mech-
anistically based, relevant measurements of
human dose-response relationships.
Without improved sensitivity ofthe meth-
ods ofhuman epidemiology, or the incor-
;' # .:
s. Hamster embryo cell cultures provide clues to
ni.
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poration of human in vitro data into the
risk characterization process, biologically
based risk assessments will simply repre-
sent improved models for the interpreta-
tion of data generated by animal experi-
mentation.
Challenges
As noted earlier, in vitro systems are gener-
ally less expensive, require less time, and
are more readily controlled than in vivo
systems. However, extrapolation from
cells and tissue cultures to the complex
human organism is at best difficult and, in
terms of producing the complex physio-
logical responses of the whole organism,
not likely at this point.
In assessing the risk presented by
chemcials and drugs during embryonic
development, Barbara Hales of McGill
University highlights the need for a more
in-depth understanding of physiological
systems. Hales points out that often it is
the balance between metabolic activation
and detoxification that determines the tox-
icity of a drug or chemical and that little
attention has been paid to the role of
detoxification pathways in the embryo in
drug teratogenicity. An essential under-
standing of basic mechanisms of normal
and abnormal development will increase
our knowledge ofthe critical developmen-
tal events such as the chemical messenger
systems that may be the target of terato-
gens.
One of the difficulties with cell cul-
tures has to do with maintaining differen-
tiated cells. Cells in culture tend to
become unspecialized after a short time,
losing the characteristics of the organ or
tissue from which they were taken. Im-
mortalized cells that have been genetically
altered could prove useful for toxicity test-
ing, though in in vitro testing one looks
for cells that respond closely to those of
the intact human body. Continuous cell
lines have undergone extensive selection
for the ability to grow in culture, whereas
normal cells have complex requirements
for growth and differentiation in culture.
More than 200 specific cell types exist in
the human body. Adequate culture sys-
tems have been developed for only a few
of these cell types. The importance and
great variety ofgrowth factors, cell regula-
tors, and mediators must also be taken
into account.
Conclusion
A wide array of new tools is now available
for toxicity testing which has the capacity
to greatly increase our knowledge of the
complex systems under investigation. At
the same time, there has not yet been a
formal process to organize, coordinate, or
evaluate the validation and implementa-
tion of advancements in in vitro testing.
Validation resources suggested in a report
from the Johns Hopkins Center include a
chemical bank, cell and tissue banks, a
data bank and reference laboratories, as
Myra Sklarew is a freelance writer in Bethesda,
Maryland.
well as the formation ofa scientific adviso-
ry board representing the academic, indus-
trial, and regulatory communities. The
report states, "A framewprk capable offos-
tering the validation of new methods is
essential for the effective transfer of new
technological developments from the
research laboratory and into practical use."
Toxicology, previously considered an
applied science, is now "a symphony ofall
methodologies from many disciplines
which attempts to protect the environ-
ment, living organisms, and nonliving
materials," notes Goldberg. "We are
entering a new era in which the rapidly
accelerating acquisition ofknowledge from
the revolution in molecular biology is
directly affecting toxicology research. The
challenge is to weave this new knowledge
and technology into the fabric of toxico-
logical research." Roger McClellan, presi-
dent ofthe Chemical Industry Institute of
Toxicology, summarizes what toxicologists
and others consider most important:
alternatives to traditional animal models
are not truly competing alternatives, but
rather additional means for attacking toxi-
cology's perplexing problems. Says
McClellan, "The challenge is to use the
knowledge and tools wisely as a comple-
ment to our other approaches."
Myra Sklarew
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